lol. parhamcyclics is the exception not the rule. he is right, biotech is a traders game. you think longs and institutional investors are responsible for the current pps?
i would say oncs - based on its current fundamental - could justify a 300-400 million market cap, but nothing beyond that until we see further progress in the trials. ino, imo, is grossly over-valued based on its current status. it hasnt even completed a phase 2 trial, while oncs - with a fraction of the resources and burn rate - is passed with p2.
oncs will be 1.5 easily within the next month or so...would not surprise me. 3-4 isnt unreasonable by the end of 2014.
small biotech is immune to general market shifts and macroeconomics factors. i wouldnt sweat any eastern european drama.
uh, no. oncs will move up on high volume. a positive article from SA, a pump and coverage from zacks and what not. biotech does not depend on real hard news to do well - look at ino, the most recent accomplishment was the mini deal with roche. imo ino is way overvalued given what it has provided. oncs is majorly undervalued and practically a bargain at these prices. still, i expect a pull back as traders take their profits
well maybe if oncs gets farther along in the trials and we see a real device maybe...but ino has more going for it (in terms of market potential and long-term value) and they havent discovered an equal partner yet...
pps is based on current fundamentals and potential, NOT current status. like most biotechs, oncs has no marketable product, it will be years before a product is ever released in the USA. biotechs typically trade 3-6x their real value, so oncs is definitely undervalued. ino is priced just right, and wont be a billion until they deliver some truly meaningful data.
oncs has awhile to go, which is good for us, much less risk than ino. but a failing ino could hit oncs hard.
either way..i expect a double or triple in the short term
actc - 1 billion shares and another billion on the way, LOL. but hey dr. lanza is a genius right? LOLOL
yeah actc is nothing but a pump and dump. NO fundamentals, NO FUTURE. massive debt, extremely diluted. putting oncs and actc in the same sentence is insulting.
sounds great except for the last paragraph. EVERY biotech lover pimps how their company is about saving lives...a good investor SHOULD NOT be a humanitarian. DO NOT invest in oncs because you think it will save lives, invest because you believe in its fundamentals.
i read the same stuff at zlcs. forget zlcs fundamentals, consider all the lives that would be saved, all the poeple living in pain, blah blah. look what happened to them, BURNED.
lol. this is how biotec works. the market isnt rational. oncs has good fundamentals...clearly the market feels new data release is immanent. this...combined with ino's surge...caused the bump in pps. now we see strong support in high .60s. i believe oncs may well hit a dollar if oncs releases something this march. it may go back to .70 as people take profits...but i dont expect to see oncs to hit .50 again in the short term.
well this is for noobies. if you understand trends and look at the history of oncs, as well as all biotechs, gains are episodic. for example, i had 20,000 shares at an average at .50. i sold high .70s 2 days ago, then the yesterday bought at .63. i now have about 26,000 shares. is this risky...yes. but i am confident oncs will not be 5 dollars in a day. they have several catalysts coming up, and oncs will rise, and then fall to a supporting position. some people have the funds to accumulate, others trade around a core position (smart, i hope to do this), but right now im interested in making money, and oncs is still a risky biotech like many others.
look at the great ino. dropping 20-30% each week...going up 50% the next...on what? have to protect urself.
nothing is in stone, but definitely this quarter or next. conference on monday, we shall see what they say. oncs isnt big on PR like ino, which is why it is less volatile. there are good and bad things about this...
lol. oncs is presenting on march 3rd. i imagine there will be a jump that week. we will hit a dollar sometime soon, next few months most likely. i sold most of my holdings at .80 yesterday and bought back in at high .60s today. so increased by shares to more than 30,000. i think this is the right way to go...as i dont see oncs maintaining huge gains in the short term. it will continue to rise and show support at higher levels, but never at an exponential rate. i think we have strong support at .60.
i dont invest in biotech because i think the fda will approve the drug or treatment. fact is 95% of all biotechs will NEVER deliver a product to market. even drugs with fda approval often burn up or dont sell well. some of the biggest jumps are in the early phases. look at eltp...my god 6 cents to 80 cents in a year! JESUS.
absent further news i actuall anticipate a small pullback sometime this week, but i do not believe .70 is where we have support could be higher .80 or even .90. if oncs delivers some hard news next month then oncs will be a dollar more certainy.
1.50 and 2.00 is great, i dont see why that wouldnt excite anyone the closer we get into trials the more risk oncs takes on. i imagine a lot of peope will bail once it approaches 1.5-2.00. any blow up in late phase trials or hiccup could destroy the pps.